Affiliation:
1. Shengjing Hospital of China Medical University
Abstract
Abstract
Background: A neonatal with severe anemia(HB:48g/L)was detected before blood transfusion. A major crossmatch-incompatible result was found with a AB donor and the further some of random 8 donors. To diagnosis the reason of anemia and the mismatched, a series serological tests were detected.
Case presentation: The AB positive neonatal was born by B positive mother and AB dad. The neonatal DAT was negative, but the elution was positive with A1 cell and negative with A2 cell. In his mother serum, titer 1024 anti-A were checked out in saline tube, after treated by DTT, titer 64 anti-A1 and 2 anti-A were checked out. The neonatal was diagnosis with Hemolytic disease of the newborn (HDFN). His mother red cell showed a weak agglutinated with anti-A under microscopy. Then was diagnosis as fetomaternal hemorrhage (FMH) through the Kleihauer-Betke test and flow cytometry. A2B red blood were given combine with phototherapy, the neonatal HB was 108g/L on the day 11 before discharged.
Conclusions: This is a rare case concurrent FMH and HDFN. The massive red cell of fetus entried maternal blood because of FMH, and then AB fetus red blood tiggered the high titer anti-A1 IgG and caused HDFN.
Publisher
Research Square Platform LLC
Reference24 articles.
1. Maternal IgG anti-A and anti-B titres predict outcome in ABOincompatibility in the neonate;Bakkeheim E;Acta Paediatr.,2009
2. de Haas, M., Thurik, F. F., Koelewijn, J. M. & van der Schoot, C. E. Haemolytic disease of the fetus and newborn. Vox Sang. 109, 99–113 (2015).
3. Impact of physician awareness on diagnosis of fetomaternal hemorrhage.Neonatology,2014,;Annemarie Stroustrup Callie
4. Roback JD.AABB TECHNICAL MANUAL.7th ed.USA.2011:370–371.
5. Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A mother;Wang M;Pediatr Blood Cancer,2005